SummaryLeukotriene B 4 (LTB 4 ) is a lipid mediator that is rapidly generated in inflammatory sites, and its functional receptor, BLT1, is mostly expressed on immune cells. Contact dermatitis is a common inflammatory skin disease characterized by skin oedema and abundant inflammatory infiltrates, primarily including neutrophils and CD8 + T cells. The role of the LTB 4 -BLT1 axis in contact dermatitis remains largely unknown. In this study, we found up-regulated gene expression of 5-lipoxygenase and leukotriene A 4 hydrolase, two critical enzymes for LTB 4 synthesis, BLT1 and elevated LTB 4 levels in skin lesions of oxazolone (OXA)-induced contact dermatitis. BLT1 deficiency or blockade of LTB 4 and BLT1 by the antagonists, bestatin and U-75302, respectively, in the elicitation phase caused significant decreases in ear swelling and skin-infiltrating neutrophils and CD8 + T cells, which was accompanied by significantly reduced skin expression of CXCL1, CXCL2, interferon-c and interleukin-1b. Furthermore, neutrophil depletion during the elicitation phase of OXA-induced contact dermatitis also caused significant decreases in ear swelling and CD8 + T-cell infiltration accompanied by significantly decreased LTB 4 synthesis and gene expression of CXCL2, interferon-c and interleukin-1b. Importantly, subcutaneous injection of exogenous LTB 4 restored the skin infiltration of CD8 + T cells in neutrophil-depleted mice following OXA challenge. Collectively, our results demonstrate that the LTB 4 -BLT1 axis contributes to OXA-induced contact dermatitis by mediating skin recruitment of neutrophils, which are a major source of LTB 4 that sequentially direct CD8 + T-cell homing to OXA-challenged skin. Hence, LTB 4 and BLT1 could be potential therapeutic targets for the treatment of contact dermatitis.